Alopecia

News

Synta Pharmaceuticals Announces First Patient Treated in Phase 1/2 Clinical Trial of Elesclomol in Prostate Cancer

Published November 20, 2008, 5:00 am, Business Wire via Yahoo! Finance

LEXINGTON, Mass.----Synta Pharmaceuticals Corp., , a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the first patient has been treated in its Phase 1/2 clinical study for its novel oxidative stress inducer, elesclomol, in combination with docetaxel in metastatic, hormone refractory ...

Full Story

Tags

No tags found at this time. Be the first to tag this news item, learn more.

Imagery


Related Alopecia Stories

From Various News Sources

No related news stories found.

Related Social Bookmarks

None found at this time.


News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a